Correction of Duncan's syndrome by allogeneic bone marrow transplantation

L. L. Williams, M. K. Brenner, R. A. Krance, H. E. Heslop, C. M. Rooney, M. E. Conley, M. E. Conley, M. K. Brenner, R. A. Krance, H. E. Heslop

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Duncan's syndrome (X-linked lymphoproliferative disorder) is a fatal immunodeficiency syndrome of unknown aetiology and without cure. We show that allogeneic bone marrow transplantation can correct the lethal immune deficits in a patient with this syndrome. We suggest that the primary abnormality in Duncan's syndrome is in bone-marrow derived cells.

Original languageEnglish (US)
Pages (from-to)587-588
Number of pages2
JournalThe Lancet
Volume342
Issue number8871
DOIs
StatePublished - Sep 4 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Correction of Duncan's syndrome by allogeneic bone marrow transplantation'. Together they form a unique fingerprint.

Cite this